scorecardresearch
Thursday, July 31, 2025
TopicCovaxin

Topic: Covaxin

Covaxin & Covishield safe for those on aspirin, vaccine factsheets will be changed — ICMR chief

Bharat Biotech and Serum Institute of India have approached Drugs Controller General of India requesting a change in factsheets on their vaccines that rule them out for those on blood thinners.

Covaxin a ‘buffet’ vaccine that can deal with mutations, others ‘a la carte’ — top virologist

India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.

Covaxin neutralises UK variant of Covid in lab setting, new ICMR paper says

Pre-print, non-peer-reviewed paper says Covaxin effective as it is made of a whole inactivated virus and not based solely on spike protein.

17% Indians in 30-69 age group may not be able to take Covaxin as they’re on blood thinner

Covaxin is contraindicated for people who use blood thinners, while Covishield asks recipients to inform physician. But doctors say there’s no rationale.

Covishield and Covaxin makers list who should avoid the vaccines as they aren’t for everyone

A selection of the best news reports, analysis and opinions published by ThePrint this week.

‘Well-tolerated, no serious adverse events’ — Lancet publishes Covaxin’s phase 1 trial data

A preprint of the results were released last month, which revealed that all three vaccine formulations in the trial resulted in 'robust immune responses'.

Vaccine solidarity? How rich nations used political, economic clout to get ahead in queue

A look at the vaccine acquisition numbers raises serious doubt about global solidarity in Covid-19 resistance.

How effective are Covid vaccines? Delhi centres to test for antibodies before & after shot

Several institutes and experts advocate see this as an efficacy trial that could help boost confidence in vaccines, especially Bharat Biotech’s Covaxin that is in phase-3 trials.

Even if Covaxin doesn’t meet efficacy mark, govt has no plan to re-vaccinate those taking it

Health ministry officials say there is no precedent for using a second vaccine, even as efficacy data is awaited on Bharat Biotech’s indigenous shot.

WhatsApp reminders, counselling, newspaper ads — how states are fighting vaccine hesitancy

Punjab, Uttarakhand & Assam plan to publish ads in newspapers, while Delhi is holding awareness sessions & interpersonal discussions to remove doubts over Covid vaccines.

On Camera

Big win for Delhi factories as MCD scraps an extra layer of red tape for ease of doing business

Until now, units operating even in recognised industrial areas needed a separate factory licence. The move is expected to especially give a boost to small and medium enterprises.

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.